Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial
- on behalf of the
- , PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016
- , PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016
Research output: Contribution to journal › Article › Research › peer-review
31
Citations
(Scopus)